MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Structural changes in non-manifesting GBA mutation carriers and GBA mutation carriers with Parkinson’s disease

    T. Yousaf, M. Kershaw, V. Suarez Contreras, P. Vickers, G. Pagano, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate whether GBA mutations are associated with structural abnormalities in a cohort of GBA mutation carriers with and without manifested PD.…
  • 2019 International Congress

    Karl Marx, Rosa Luxemburg, and Deep Brain Stimulation: is there a connection?

    M. Hariz, P. Krack, A. Lees (Umea, Sweden)

    Objective: To investigate possible reasons behind some practices of deep brain stimulation (DBS) hardware providers. Background: The global success of DBS in movement disorders has…
  • 2019 International Congress

    Does Deep Brain Stimulation in Parkinson’s Disease Change Disease Progression in the Long Run?

    A. Løkkegaard, B. Jespersen, M. Karlsborg, A. Clausen, S. Jensen, B. Thomsen (Copenhagen, Denmark)

    Objective: This is one of the first studies investigating the progression of disease and mortality of patients with Parkinson’s Disease (PD) 8-15 years after Deep…
  • 2019 International Congress

    PARKMIM: A Transversal Pilot Study on Hemihypomimia in Parkinson Disease

    M. Kurtis, C. Gasca, T. Maycas-Cepeda, P. Gomez-Sanchez, L. Lopez-Manzanares, M. Mata Alvarez-Santullano, C. Prieto-Jurcczynska, M. Eimil, L. Vela, A. Jimenez-Huete (Madrid, Spain)

    Objective: To describe the prevalence of facial asymmetry due to hemihypomimia in a non fluctuating Parkinson disease (PD) cohort and compare it to age-matched controls.…
  • 2019 International Congress

    The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease

    B. Bernard, G. Stebbins, A. Negron, D. Merkitch, J. Goldman (Chicago, IL, USA)

    Objective: To assess the relationship between individual items from the Neuropsychiatric Inventory and five cognitive domains in patients with Parkinson's disease (PD) and normal cognitive…
  • 2019 International Congress

    Relationships of gender, care models, and neuropsychiatric symptoms in Parkinson’s disease

    J. Goldman, S. Wu, C. Martinez-Rubio, V. Todaro (New York, NY, USA)

    Objective: To examine relationships among gender, care models, and presence and management of neuropsychiatric symptoms of Parkinson’s disease (PD). Background: Neuropsychiatric symptoms such as depression…
  • 2019 International Congress

    Evaluating Volume Changes in the Substantia Nigra Pars Compacta (SNc) in Parkinson’s Disease (PD) in a Study-Specific Magnetic Resonance Imaging (MRI) Template

    E. Biondetti, R. Gaurav, L. Yahia-Cherif, G. Mangone, N. Pyatigorskaya, R. Valabregue, C. Ewenczyk, M. Hutchison, JC. Corvol, MJ. Vidailhet, S. Lehéricy (Paris, France)

    Objective: To characterize the topography of SNc involvement in PD patients using neuromelanin (NM)-sensitive MRI (NM-MRI). Background: PD is characterized by the progressive loss of…
  • 2019 International Congress

    “Brain-first” vs. “body-first” Parkinson’s disease is determined by RBD-status – a multi-modality imaging study

    J. Horsager, K. Knudsen, K. Andersen, C. Skjærbæk, T. Fedorova, J. Geday, J. Kraft, E. Bech, E. Danielsen, M. Møller, N. Pavese, D. Brooks, P. Borghammer (Aarhus N, Denmark)

    Objective: In a multi-modality imaging study, we test the hypothesis that Parkinson’s disease (PD) can be divided into two strikingly distinct phenotypes: (1) PD patients,…
  • 2019 International Congress

    Functional Biomarkers of Parkinson’s Disease: Changes in Brain-Wide Network Connectivity in Default Mode and Fronto-Parietal Control Networks

    P. Macdonald, N. Hiebert, L. Naci, A. Owen (Dublin, Ireland)

    Objective: Parkinson’s disease (PD) is a neurological disorder with no reliable biomarkers. We aimed to investigate naturalistic paradigms as functional biomarkers that distinguish between PD…
  • 2019 International Congress

    Genotype influences circuit compensation in Parkinson’s disease

    K. Schindlbeck, A. Vo, N. Nguyen, C. Tang, M. Niethammer, V. Dhawan, V. Brandt, R. Saunders-Pullman, S. Bressman, D. Eidelberg (Manhasset, NY, USA)

    Objective: This study investigates differences in brain network organization in patients with Parkinson’s disease (PD) with genetic risk factors relative to sporadic PD patients and…
  • « Previous Page
  • 1
  • …
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley